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Abstract
We examine the efficiency of a number of schemes to select cases from nuclear families for case-
control association analysis using the Genetic Analysis Workshop 14 simulated dataset. We show
that with this simulated dataset comparing all affected siblings with unrelated controls is
considerably more powerful than all of the other approaches considered. We find that the test
statistic is increased by almost 3-fold compared to the next best sampling schemes of selecting all
affected sibs only from families with affected parents (AFaff), one affected sib with most evidence of
allele-sharing from each family (SF), and all affected sibs from families with evidence for linkage
(AFL). We consider accounting for biological relatedness of samples in the association analysis to
maintain the correct type I error. We also discuss the relative efficiencies of increasing the ratio of
unrelated cases to controls, methods to confirm associations and issues to consider when applying
our conclusions to other complex disease datasets.
Background
Case-control association studies are regaining popularity
in the challenge to identify markers conferring susceptibil-
ity to complex diseases. A sample of affected cases is com-
pared to a sample of suitable controls to test for
association between allelic variants and disease status. In
the recent past, family-based association designs were
advocated to protect against spurious associations arising
from population substructure. However, such designs are
2- to 5-fold less efficient than using unrelated controls [1].
Furthermore, methods such as genomic control and struc-
tured association have since been developed to detect and
account for population stratification. These methods rely
on the premise that stratification would lead to differ-
ences in allele frequencies between two or more popula-
tions and that these differences could be detected by
analyzing anonymous markers [2-4].
Further improvements in power can be obtained by
including sibships with multiple affected sibs that are
readily available from prior linkage studies [1]. Most of
this gain is generally attributable to an increased allele fre-
quency difference between related cases and unrelated
controls. When the number of affected relatives increases,
the expected allele frequency of the high-risk allele
increases in the cases but remains the same in the unre-
lated controls. In contrast, the frequency of the high-risk
allele also increases in the control group when related
controls are used.
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Where genotyping more than one sibling from a family is
cost prohibitive, it may be useful to select the most
informative sib for association analysis. A recent study
used allele sharing to select the most informative sib from
sibships of various sizes and found that choosing the sib
showing the greatest allele sharing from each sibship
increased the efficiency of case-control associations under
a variety of genetic models [5].
When using related subjects in case-control studies the
correlations among relatives must be accounted for in the
statistical analysis to avoid an increase in type I error. A
number of tests have been proposed that take account of
the sampling of biologically related subjects in the vari-
ance of test statistic. Risch and Teng [1] propose a trans-
mission disequilibrium test- (TDT) like statistic for sibling
data; Slager and Schaid [6] advocate an adjusted trend test
that allows cousin data to be used as well as sibling data;
Bourgain et al. [7] suggest a quasi-likelihood trend test,
particularly when cases are selected from complex inbred
pedigrees.
Here we examine the efficiency of a number of strategies
for selecting cases from nuclear families with multiple
affected subjects and comparing with unrelated controls
to identify a known Kofendrerd Personality Disorder
(KPD) disease susceptibility marker on a region of chro-
mosome 5. We examine the efficiencies of a number of
case selection strategies including those proposed by Fin-
gerlin et al. [5] and Risch and Teng [1]. The test statistic at
the disease locus for each selection scheme is compared
with the maximum test statistic we observed, and the
number of other associated markers identified is also con-
sidered. We discuss the impact of over-sampling controls
relative to cases and present approaches for confirming
putative associations.
Methods
Data
The Genetic Analysis Workshop 14 (GAW14) simulated
dataset was used for this analysis. A region of chromo-
some 5 was known to us to contain a susceptibility locus
for KPD and was chosen for investigation. The actual dis-
ease locus was originally blinded from those doing the
association analysis. However, it became clear from the
analysis which marker was the true association and hence
results are reported with reference to the known answer.
Data packages 206–210 containing 100 markers were
used. The Aipotu family dataset (001) with KPD affection
status was initially used for the analysis. Unrelated control
populations of various sizes (50, 100, 200, 400, and
1,000) were created by randomly combining control rep-
lication sets (replicates 001–020). The control data sets
for each scheme contained approximately the same
number of unrelated controls as affected cases, with differ-
ent randomly selected controls used in each scheme.
Case selection schemes
Seven case selection strategies were compared. We
selected one affected sibling at random from each family
(RF), all affected siblings from each family (AF), and all
affected sibs from families with one or both parents
affected (AFaff). We also selected sibs on the basis of link-
age and allele sharing information. Families with evi-
dence for linkage were defined as those with a multipoint
linkage NPL score >0 in the chromosome 5 region (cen-
tered at D05S0172) (calculated using GENEHUNTER
[8]). We employed schemes using one sibling selected at
random from families with evidence for linkage (RFL) and
all siblings from those families (AFL). The selection of sib-
lings with the most evidence for allele-sharing was
achieved by using the IBD probabilities for each family
[5]. The schemes considered used one affected sib from
each family with the most evidence for allele sharing (SF)
and one affected sib with the most evidence for allele shar-
Table 1: Summary of each selection strategy
Schemea No. families No. cases No. controls Allele freq 
cases
Allele freq 
controls
Difference 
allele freq
Test statistic Relative 
efficiency (%)
No. other positive 
markers
RF 100 100 100 0.350 0.255 0.095 4.28 22 3
AF 100 233 200 0.384 0.232 0.152 18.20 93 7
AFaff 47 118 100 0.386 0.255 0.131 6.43 33 4
RFL 50 50 50 0.350 0.260 0.090 1.19 9 5
AFL 50 110 100 0.373 0.255 0.118 5.35 27 4
SF 100 100 100 0.365 0.255 0.111 5.66 29 4
SFL 50 50 50 0.360 0.260 0.100 2.33 11 4
aRF = One affected sib selected randomly from each family, AF = All affected sibs selected from each family, AFaff = All affected sibs selected from 
families with affected parents, RFL = One affected sib selected randomly from families with evidence for linkage, AFL = All affected sibs from families 
with evidence for linkage, SF = One affected sib with most evidence of allele-sharing from each family, SFL = One affected sib with most evidence of 
allele-sharing from families with evidence for linkage.BMC Genetics 2005, 6:S105
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ing in families with evidence for linkage (SFL). The
schemes are summarized in Table 1.
Comparison of selection strategies
Because some of the selection schemes include multiple
siblings per family, the test statistic proposed by Risch and
Teng [1] was used to test for single-nucleotide polymor-
phism (SNP) marker associations in the region, with the
adaptation of using the average number of siblings per
family. The test statistic is of the form  ,
where   and   are the estimated allele frequencies of
the SNP marker in the cases and controls, and   is the
estimated standard deviation of the difference.
The test statistic is defined as
in which
The average number of affected sibs per family is denoted
r, n is the number of families, and u represents the number
of unrelated controls per family.   and   represent
the number of marker alleles carried by case i and control
i,, respectively. The test statistic is distributed as a chi-
squared with 1 degree of freedom.
The test statistic was calculated for all of the markers in the
region using SAS ® (SAS version 8.2, SAS Institute Inc.,
Cary, NC, USA) and markers yielding p < 0.05 were con-
sidered further. To compare the efficiencies of the selec-
tion strategies the ratio of the test statistic at the disease
locus for the given selection scheme to the maximum test
statistic obtained (using all affected sibs and 5 times the
number of controls, test statistic = 19.47) was used. The
number of other markers in the region showing evidence
of association (p < 0.05) to KPD but not identified as the
causal variant was also noted. Linkage disequilibrium
(LD) across the region was visualized using the program
HELIXTREE [9]. The program TRANSMIT [10] was used to
calculate the TDT test for the disease susceptibility marker.
Results and discussion
Identification of disease locus
The efficiencies of the seven selection schemes using equal
ratios of cases to controls are shown in Table 1. The most
efficient scheme was sampling all affected individuals (n
= 233) (AF) and 5 times the number of controls, which
gave a test statistic of 19.47. However, using an equal
number of controls resulted in a mere 7% reduction in
efficiency. The AF scheme was considerably more power-
ful than the any of the other selection strategies, with a
greater than 2.5-fold increase in the test statistic than the
next best approaches; AFaff (n = 118), SF (n = 100), and
AFL (n = 110), with efficiencies of 33%, 29%, and 27%,
respectively. The remaining approaches were particularly
lacking in power with efficiencies in the range of 22% to
9%. The number of other positives (p < 0.05) identified
was approximately the same across all of the selection
schemes.
The higher efficiency of the AF scheme relative to the other
schemes may be attributable to the larger sample size
alone. However, others have shown that the gain in effi-
ciency of such a design is due to an increase in the disease
allele frequency in the case group rather than sample size
[1]. In this study, the average number of affected siblings
per family was 2.33 (range 2 to 7). It would be interesting
to explore the impact of sampling a greater number of sib-
lings per family but we were unable to do this due to the
limitations of the simulated dataset. Table 1 shows the
risk allele frequency for the case sampling schemes; the AF
and AFaff schemes result in the greatest enrichment for the
risk allele followed by AFL, SF, SFL, RFL, and RF. This rank-
ing corresponds well with ranking on the difference in the
risk allele between cases and controls (differences were
observed in the risk allele frequency for each of the con-
trol groups as controls were selected randomly for com-
paring with cases from each of the selection schemes).
Although using all available cases from families may be
preferable, from a genotyping perspective, this may not be
feasible. When restricted to using only one affected sibling
from each family we show that selecting the sib with the
greatest allele sharing in a family results in a greater effi-
ciency than randomly selecting an affected sib from each
family, as observed by Fingerlin et al. [5].
Although these findings hold true for the specific genetic
and phenotypic models used in the simulated data set, it
is not clear how robust these findings are across a range of
genetic models (e.g., allele frequency, dominance, epista-
sis, penetrance, LD between marker and causal variant(s))
and phenotypic traits (e.g., continuous and categorical).
However, it is beyond the scope of this article to investi-
gate the impact of these factors on the selection strategies
considered here.
Confirmation of the disease locus
The risk locus for KPD on chromosome 5, B05T4136, was
identified in the Aipotu population. In addition to the dis-
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ease locus a number of other markers were found to be
statistically associated with KPD. We attempted to
strengthen confidence in the association by using a
number of methods described below.
We examined the pair-wise marker LD across the region
(Figure 1) using D' and r and found it to be low. This was
not surprising given an average marker density of 1 per 0.3
cM. The known susceptibility marker was not found to be
in strong LD with any of the markers genotyped in the
region.
We next considered the potential existence of population
stratification. We used a family-based TDT test of associa-
tion to control for population stratification. The disease
locus was found not to be associated, although a trend of
increased transmissions of the risk allele was observed.
Although the TDT is robust to population stratification, it
is somewhat less powerful than case-control sampling
[11]. The reduction in power is not only due to the smaller
difference in allele frequency between cases and controls,
as discussed above, but also because of the lower sample
size. The reduction in sample size is attributable to only
heterozygous parents being informative in the TDT,
resulting in at least a third greater sampling and genotyp-
ing being needed compared to case-control sampling.
In addition to attempting to replicate the association in
the same population, we also considered replicating in the
available Karangar population. This marker was found
not to be associated in the Karangar population. There are
a number of reasons for not being able to replicate across
populations. There could be important differences in
allele frequency or LD structure across populations, result-
Linkage disequilibrium plot for 95 SNPs across the KPD region Figure 1
Linkage disequilibrium plot for 95 SNPs across the KPD region. The upper left triangle shows the pair-wise r values 
(labelled as LD correlation, R) and the lower right hand triangle shows pair-wise D' values (labelled d prime). Red indicates val-
ues of r or D' close to 1, blue represents values close to 0.Publish with BioMed Central    and   every 
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ing in the risk allele exhibiting a different pattern of asso-
ciation with marker alleles and haplotypes in the different
populations [12]. Hidden population stratification can
further complicate this situation by producing spurious
association or changing the pattern of a true association
[4,13-16]. Locus and allelic heterogeneity are also possi-
ble explanations.
Conclusion
In the GAW14 simulated dataset we have shown that
comparing all available cases from nuclear families with
unrelated controls in an association study is considerably
more powerful than any of the case selection schemes
considered. However, strategies using all affected siblings
with affected parents or cases with strong allele-sharing
result in comparable enrichment of the risk allele but with
fewer cases being selected. Although our results are similar
to those published by other investigators, we suggest a
degree of caution when generalizing all of these findings.
Further investigation into the robustness of the results
over a range of genetic and phenotypic models is required.
Abbreviations
AF: All affected sibs selected from each family
AFaff : All affected sibs selected from families with affected
parents
AFL: All affected sibs from families with evidence for link-
age
GAW14: Genetic Analysis Workshop 14
KPD: Kofendrerd Personality Disorder
LD: Linkage disequilibrium
RF: One affected sib selected randomly from each family
RFL: One affected sib selected randomly from families
with evidence for linkage
SNP: Single-nucleotide polymorphism
TDT: Transmission disequilibrium test
SF: One affected sib with most evidence of allele-sharing
from each family
SFL: One affected sib with most evidence of allele-sharing
from families with evidence for linkage
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